Language Select


Recent News
Jul 18, 2017

Varian Medical Systems (NYSE: VAR) announced today that radiation oncology professionals using its Eclipse™ treatment planning software created the top scoring head and neck cancer treatment...

Jul 11, 2017

A 68-year-old breast cancer patient has become the first person in the nation of Georgia to be treated using the Edge™ radiosurgery system from Varian Medical Systems (NYSE: VAR) in combination...

Jun 29, 2017

Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for its Halcyon™ system, its new device for cancer treatment. Halcyon simplifies and enhances virtually every aspect of...

More news >

Recent Blog Posts
Jul 11, 2017Spot ON
The number of operational treatment rooms will likely double within the next five years. While patients will have more access to proton therapy, the growth of new centers presents new challenges. Learn how Varian is mitigating these challenges using knowledge-based treatment planning.
Read more
Jun 21, 2017Spot ON
User-focused design is a corner stone of Varian’s product realization process. The recent usability evaluation of the in-room CT workflow on the ProBeam system received positive feedback by users at HollandPTC.
Read more
Jun 7, 2017Centerline
RapidPlan™ knowledge-based planning is helping clinicians at centers around the world achieve greater consistency, efficiency, and quality in radiotherapy treatment planning.
Read more
Corporate Communications Contacts
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.